Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00488) | |||||
---|---|---|---|---|---|
Name |
Omega-3 carboxylic acid
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Epanova; Omega-3 Fatty Acids; Fatty Acids, Omega-3; n-3 PUFA; n-3 Polyunsaturated Fatty Acid; n-3 PUFAs; Omega-3 Polyunsaturates; Polyunsaturated Fatty Acids (PUFAs); F005100000
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Hypertriglyceridaemia | ICD-11: 5C80 | [1] | ||
PubChem CID | |||||
Formula |
C60H92O6
|
||||
Canonical SMILES |
CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O.CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O.CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O
|
||||
InChI |
1S/C22H32O2.C20H30O2.C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24);3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22);3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-;4-3-,7-6-,10-9-,13-12-,16-15-;4-3-,7-6-,10-9-
|
||||
InChIKey |
QPEOIOLHJXXJFN-GNGJDXFDSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=56842239"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 909.4 | Topological Polar Surface Area | 112 | |
XlogP | N.A. | Complexity | 1160 | ||
Heavy Atom Count | 66 | Rotatable Bond Count | 40 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Omega-3 carboxylic acid 1000 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Butyl alcohol; Ethyl acrylate; Isopropyl alcohol; Sorbitol; Ferric oxide red; Glycerin; Propylene glycol; Talc; Titanium dioxide; Water; Carboxymethylcellulose sodium; Polysorbate 80; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AstraZeneca | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [2] | |||
Ethyl acrylate | DIG Info | NFE2-related factor 2 (EC50 = 5110 nM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Carboxymethylcellulose sodium | DIG Info | Albendazole monooxygenase (EC50 = 12.6 uM) | [6] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.